Sophie Fagg (@SFagg_ER) header
Sophie Fagg (@SFagg_ER) profile picture

Commissioning Editor at Taylor & Francis | Expert Review of Anticancer Therapy | Expert Review of Respiratory Medicine | All views expressed are my own.

London, UK
Joined September 2013
Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)
Checkpoint inhibitors in advanced melanoma https://teapawt.org/t.co/YHHN7OFBBJ #ESMO2017 #HotTopic
Postoperative stereotactic radiosurgery for limited brain metastases: are we ready for prime time? https://teapawt.org/t.co/xhcMJWtx2k #ESMO2017
Olaratumab for the treatment of advanced soft tissue sarcoma https://teapawt.org/t.co/1qSmWfHyTI #ESMO2017 #Sarcoma
Improving postoperative radiotherapy following radical prostatectomy https://teapawt.org/t.co/cCapGMJjQA #OpenAccess
Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer https://teapawt.org/t.co/eMxMyU2NAE #prostate #ESMO2017
Expert Review of Anticancer Therapy welcomes unsolicited content - submit yours today! mc.manuscriptcentral.com/ert #ESMO2017
1
Hepatocellular carcinoma discussion at #ESMO2017 later today! Read our review on proton beam therapy for HCC! https://teapawt.org/t.co/NNofFQpeFa
A lot of discussion surrounding melanoma treatments at #esmo2017. Take a look at our recent article on Binimetinib https://teapawt.org/t.co/WCfBVIFOGJ
Proton beam therapy for hepatocellular carcinoma https://teapawt.org/t.co/NNofFQpeFa
Reviewing the use of #Nivolumab for the treatment of #melanoma - new article now online: https://teapawt.org/t.co/efrjPxaLcb
New FREE Editorial: Paul Huang from @ICR_London discusses using TKI therapy to target SWI/SNF mutant cancers https://teapawt.org/t.co/rf2zSpwaTW
1
2
3
Special considerations in managing elderly and unfit patients with chronic lymphocytic #leukemia https://teapawt.org/t.co/NRcyqg7oZy #hematology
Is #Betrixaban the next direct factor Xa inhibitor? Peter Bramlage reviews the evidence: https://teapawt.org/t.co/9iSI7uPYQA #hematology
New supplement on guiding decision-making for main treatment options of surgery, chemotherapy and targeted therapy for ovarian cancer teapawt.org/ERJournals/status/7954…
New challenges for hematologists: #MDS and acute #leukemia with genetic predispositions, new review now online: https://teapawt.org/t.co/q4ywFXKnP8
#FREE Access to October issue of Precision Med & Drug Development until end of November! https://teapawt.org/t.co/f4BcqHocVH #PersonalizedMedicine
11
1
Access to October Issue of QoL in Cancer Care #FREE until the end of November! https://teapawt.org/t.co/MaTK9ylkL8 #Cancer #CancerCare #QoL #palliative
When to use immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma? https://teapawt.org/t.co/SkvhUalaZR
#Lenvatinib for treatment of radioiodine-refractory differentiated thyroid carcinoma: Pawel Kawalec et al reviews: https://teapawt.org/t.co/BrisMR5BE0
Tackling relative anemia in sickle cell disease in sub-Saharan Africa, new review from Michael DeBaun: https://teapawt.org/t.co/entA6quKgp #sicklecell